Federal Register / Vol. 67, No. 1 / Wednesday, January 2, 2002 / Notices 83

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues.

Date and Time: The meeting will be 

held on January 16, 2002, from 10 a.m. 

to 12:30 p.m.

Location: Holiday Inn, Versailles 

Ballrooms I and II, 8120 Wisconsin 

Ave., Bethesda, MD.

Contact: William Freas, or Sheila D. 

Langford, Center for Biologics 

Evaluation and Research (CBER) (HFM–

17), Food and Drug Administration, 

1401 Rockville Pike, Rockville, MD 

20852–1448, 301–827–0314, or FDA 

Advisory Committee Information Line, 

1–800–741–8138 (301–443–0572 in the 

Washington, DC area), code 19516. 

Please call the Information Line for upto-date information on this meeting.

Agenda: On January 16, 2002, the 

committee will hear presentations 

relevant to the site visit report on the 

review of the research programs of the 

Laboratory of Bacterial, Parasitic, and 

Unconventional Agents, and the 

Laboratory of Molecular Virology, 

Division of Emerging and Transfusion 

Transmitted Diseases, Office of Blood 

Research and Review, CBER.

Procedure: On January 16, 2002, from 

10:00 a.m. to 10:45 a.m., and from 11:30 

a.m. to 12:30 p.m. the meeting is open 

to the public. Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person by January 9, 2002. Oral 

presentations from the public will be 

scheduled between approximately 11:30 

a.m. to 12:30 p.m. on January 16, 2002. 

Time allotted for each presentation may 

be limited. Those desiring to make 

formal oral presentations should notify 

the contact person before January 9, 

2002, and submit a brief statement of 

the general nature of the evidence or 

arguments they wish to present, the 

names and addresses of proposed 

participants, and an indication of the 

approximate time requested to make 

their presentation.

Closed Committee Deliberations: On 

January 16, 2002, from 10:45 a.m. to 

11:30 a.m., the meeting will be closed to 

permit discussion where disclosure 

would constitute a clearly unwarranted 

invasion of personal privacy (5 U.S.C. 

552b(c)(6)). The committee will discuss 

the reports of the review of individual 

research programs in the Division of 

Emerging and Transfusion Transmitted 

Diseases, Office of Blood Research and 

Review, Center for Biologics Evaluation 

and Research.

FDA regrets that it was unable to 

publish this notice 15 days prior to the 

January 16, 2002, Blood Products 

Advisory Committee meeting. Because 

the agency believes there is some 

urgency to bring this issue to public 

discussion and qualified members of the 

Blood Products Advisory Committee 

were available at this time, the 

Commissioner of Food and Drugs 

concluded that it was in the public 

interest to hold this meeting even if 

there was not sufficient time for the 

customary 15-day public notice.

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2).

Dated: December 26, 2001.

Linda A. Suydam,

Senior Associate Commissioner.

[FR Doc. 01–32253 Filed 12–27–01; 5:02 pm]

BILLING CODE 4160–02–S

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of Inspector General 

Program Exclusions: November 2001

AGENCY: Office of Inspector General, 

HHS.

ACTION: Notice of program exclusions.

During the month of November 2001, 

the HHS Office of Inspector General 

imposed exclusions in the cases set 

forth below. When an exclusion is 

imposed, no program payment is made 

to anyone for any items or services(other 

than an emergency item or service not 

provided in a hospital emergency room) 

furnished, ordered or prescribed by an 

excluded party under the Medicare, 

Medicaid, and all Federal Health Care 

programs. In addition, no program 

payment is made to any business or 

facility, e.g., a hospital, that submits 

bills for payment for items or services 

provided by an excluded party. Program 

beneficiaries remain free to decide for 

themselves whether they will continue 

to use the services of an excluded party 

even though no program payments will 

be made for items and services provided 

by that excluded party. The exclusions 

have national effect and also apply to all 

Executive Branch procurement and nonprocurement programs and activities.

Subject city, state Effective 

date 

Program-Related Convictions

Bilenkin, Elana .......................... 12/20/2001

Old Bridge, NJ 

Birdsong, Stacie ....................... 12/20/2001

Detroit, MI 

Bitz, Jennifer M ......................... 12/20/2001

Jamestown, ND 

Subject city, state Effective 

date 

Boguslavskiy, Vadim ................ 12/20/2001

Lavenel, NJ 

Brown, Maurice Chevale .......... 12/20/2001

Sterling, CO 

Dallakyan, Naira M ................... 12/20/2001

Pasadena, CA 

Greer, J Randall ....................... 12/20/2001

Memphis, TN 

Gutman, Marci .......................... 12/20/2001

Miami, FL 

Maddox, Yolanda Gail .............. 12/20/2001

Troy, AL 

McDonald, Anita Fletcher ......... 12/20/2001

Palestine, TX 

New York Health Plan .............. 12/20/2001

New York, NY 

Norman, Brigid .......................... 12/20/2001

Riverdale, GA 

Paulin, John Gregory ................ 12/20/2001

Florence, CO 

Rapp, Donna Lynn ................... 12/20/2001

Lakewood, CO 

Reyes, Gloria ............................ 12/20/2001

Miami, FL 

Rose, Melba L .......................... 12/20/2001

Miami, FL 

Scarpitta, Janet ......................... 12/20/2001

Newark, NJ 

Stolyar, Yelena ......................... 12/20/2001

Golden, CO 

Taylor, Shirley Jean .................. 12/20/2001

Pearl, MS 

Urban, Edward J ....................... 12/20/2001

Chargin Fall, OH 

Felony Conviction for Health Care

Brathwaite, Stephen Earl .......... 12/20/2001

W Valley City, UT 

Burstein, Donald A ................... 12/20/2001

Warminster, PA 

Casiano, Janet .......................... 12/20/2001

Carle Place, NY 

Fergusson, Olantungie Clarence ...................................... 12/20/2001

Sherman Oaks, CA 

Oldham, Susan G ..................... 12/20/2001

Lexington, KY 

Runk, Lisa D ............................. 12/20/2001

Wichita, KS 

Seals, Carlos V ......................... 12/20/2001

Los Angeles, CA 

Felony Control Substance Conviction

Davis, Donna K Kidd ................ 12/20/2001

Somerset, KY 

Gleason, Laura Jane ................ 12/20/2001

Phoenix, AZ 

Hendrick, Vickie ........................ 12/20/2001

Gallatin, TN 

McMenamin, Deborah J ........... 12/20/2001

Carbondale, PA 

Sommer, Deborah Jane ........... 12/20/2001

Dayton, TX 

Patient Abuse/Neglect Convictions

Barsuk, Joseph Jr ..................... 12/20/2001

Churchville, NY 

Boykins, Loretta Penny ............ 12/20/2001

Baltimore, MD 

Cathey, Deborah ...................... 12/20/2001

84 Federal Register / Vol. 67, No. 1 / Wednesday, January 2, 2002 / Notices 

Subject city, state Effective 

date 

Nashville, TN 

Coleman, Tracy Lavonne ......... 12/20/2001

Laurora, CO 

Conyers, Leonard E ................. 12/20/2001

Wilmington, DE 

Dickinson, Sharon Lee ............. 12/20/2001

Corunna, MI 

Ferdon, Michael Kevin .............. 12/20/2001

Ontario, OR 

Kegel, Alan ............................... 12/20/2001

Wheeling, IL 

Lembong, Noky Herems ........... 12/20/2001

Diamond Bar, CA 

Maxian, Therese M ................... 12/20/2001

Binghamton, NY 

Pawlak, Patricia ........................ 12/20/2001

Barker, NY 

Quinones, Anel ......................... 12/20/2001

Garfield, NJ 

Risley, Charles ......................... 12/20/2001

S Saugerties, NY 

Stocker, Charles Edward .......... 12/20/2001

Lancaster, OH 

Thompson, Robert J ................. 12/20/2001

Raymond, MS 

Watson, Marlene Maria ............ 12/20/2001

Bronx, NY 

Conviction for Health Care Fraud

Plyter, Mark .............................. 12/20/2001

Williamson, NY 

License Revocation/Suspension/

Surrendered

Amundson, Terri Sue ............... 12/20/2001

Lawrenceville, GA 

Banda-Orman, Selina ............... 12/20/2001

Des Moines, IA 

Barolin, Linda ............................ 12/20/2001

Mantua, NJ 

Bealer, Mildred Sitch ................ 12/20/2001

Pottsville, PA 

Bell, Donna S ........................... 12/20/2001

Douglas, AK 

Bryant, Laurie L ........................ 12/20/2001

Davenport, IA 

Burgess, Marleen K .................. 12/20/2001

Cresco, IA 

Carico, Paula J ......................... 12/20/2001

Kendallville, IN 

Cigelske, Michael Allen ............ 12/20/2001

Phoenix, AZ 

Duffie, Brenda L ....................... 12/20/2001

Burlington, IA 

Dykes, Judy R .......................... 12/20/2001

Phoenix, AZ 

Garrett, Herman Alpha ............. 12/20/2001

Norcross, GA 

Harple, Carol Weiler ................. 12/20/2001

Gordonville, PA 

Hernandez, Stephen Louis ....... 12/20/2001

Hudson, FL 

Heuberger, Sally ....................... 12/20/2001

Sheffield, IA 

Hummell, Alan .......................... 12/20/2001

Cocoa, FL 

Jewkes, Mindy .......................... 12/20/2001

Salt Lake City, UT 

Kadish, William A ..................... 12/20/2001

Shrewsbury, MA 

Larson, Richard Warren ........... 12/20/2001

Cherokee Village, AR 

Subject city, state Effective 

date 

Leonard, Rhonda Lynn ............. 12/20/2001

Tyler, TX 

Long, Jill Suzanne .................... 12/20/2001

W Blocton, AL 

Lucero, Glen M ......................... 12/20/2001

Denver, CO 

McGraw, Daniel P .................... 12/20/2001

Haverhill, MA 

Milam, Stephen Robert ............. 12/20/2001

Cicero, IN 

Moore, Jerry Gayle ................... 12/20/2001

Houston, TX 

Newman, William T .................. 12/20/2001

Chapel Hill, NC 

Petanovich, E John .................. 12/20/2001

Emlenton, PA 

Peyton, Bret W ......................... 12/20/2001

Iowa Falls, IA 

Porter, Mary Jo ......................... 12/20/2001

Norfolk, VA 

Rice, Cynthia M ........................ 12/20/2001

Phoenix, AZ 

Richardson, Lawrence John ..... 12/20/2001

Los Angeles, CA 

Rollins, Jane ............................. 12/20/2001

Michigan City, IN 

Shellhase, Barbara J ................ 12/20/2001

Cleona, PA 

Spencer, Craig A ...................... 12/20/2001

Frankfort, IL 

Sugden, Mark F ........................ 12/20/2001

Virginia Beach, VA 

Tabotabo, Armando M .............. 12/20/2001

Keyport, NJ 

Vail, Sheree Behr ..................... 12/20/2001

Malvern, PA 

Wehby, Michael Daniel ............. 12/20/2001

Fort Thomas, KY 

West, Malynda Susan .............. 12/20/2001

San Francisco, CA 

Fraud/Kickbacks

Rousseau, Andre M .................. 09/10/2001

Chicago, IL 

Entities Owned/Controlled By Convicted

Arroyo Chiropractic ................... 12/20/2001

Arroyo Grande, CA 

Carlin Chiropractic Health Ctr .. 12/20/2001

San Antonio, TX 

Cosmetic Surgery & Laser Inst 12/20/2001

Tustin, CA 

Gregory W Stephens, D C, P C 12/20/2001

Houston, TX 

Lund Chiropractic ..................... 12/20/2001

Arlington, TX 

Martin Family Chiropractic Ctr .. 12/20/2001

Cameron Park, CA 

Y & L Corporation ..................... 12/20/2001

Denver, CO 

Default on Heal Loan

Alams, Humphrey A Jr ............. 12/20/2001

Seattle, WA 

Anillo-Sarmiento, Manuel F ...... 12/20/2001

Miami, FL 

Baron, Spencer H ..................... 12/20/2001

N Miami Beach, FL 

Bell, Robert E ........................... 12/20/2001

Phoenix, AZ 

Bornstein, Mark L ..................... 12/20/2001

Subject city, state Effective 

date 

Pembroke Pines, FL 

Buckingham, Guy M ................. 12/20/2001

Orleans, MI 

Dauphin, Michelle M ................. 12/20/2001

Pembroke Pines, FL 

Dinozzi, Anthony D ................... 12/20/2001

Batavia, OH 

Dupuis, Edward J ..................... 12/20/2001

Dallas, TX 

Evans, Charla J ........................ 12/20/2001

Mobile, AL 

Ferguson, Camilla M ................ 12/20/2001

Fairborn, OH 

Fredericks, Duane A ................. 12/20/2001

Philadelphia, PA 

Fryer, Thomas J ....................... 12/20/2001

Ferron, UT 

Gilyot, Glenn David Sr .............. 12/20/2001

New Orleans, LA 

Hansen, Hunter J ..................... 12/20/2001

Andrews, NC 

Havriliak, Stephen J ................. 12/20/2001

Huntingdon Valley, PA 

Huber, Mark .............................. 12/20/2001

Princeton, MN 

Kardelis, Eugene C Jr .............. 12/20/2001

Nazareth, PA 

Kardos, William P ..................... 12/20/2001

Apollo, PA 

Knott, Kevin Thomas Jr ............ 12/20/2001

Oceanside, CA 

Kron, Kathy A ........................... 12/20/2001

Norton, MA 

Lallouz, Solomon Y .................. 12/20/2001

Hollywood, FL 

Lantz, Larry S ........................... 12/20/2001

Broomall, PA 

Leavitt, Albert M Jr ................... 12/20/2001

Alexandria, VA 

Legault, Michelle A ................... 12/20/2001

Coon Rapids, MN 

Leon, Maria I ............................ 12/20/2001

Hollywood, FL 

Levy, Richard S ........................ 12/20/2001

Forthee, NJ 

Milbourne, Michael W ............... 12/20/2001

Lafayette Hill, PA 

Milot, Sheila Inez ...................... 12/20/2001

Vernon Hills, IL 

Moore, Charles E ..................... 12/20/2001

Kansas City, KS 

O’Brien, Matthew P .................. 12/20/2001

Romeo, MI 

Parenti, Lisa C .......................... 12/20/2001

Nashville, TN 

Parker, Melissa M ..................... 12/20/2001

Clinton, NC 

Parsons, Tien M ....................... 12/20/2001

Marathon, FL 

Payne, Carrol D ........................ 12/20/2001

Memphis, TN 

Pitts, Angela R .......................... 12/20/2001

Odessa, FL 

Powell, Michael N ..................... 12/20/2001

Wollaston, MA 

Pugh, Melvoria C ...................... 12/20/2001

Mobile, AL 

Ray, Donald Elton .................... 12/20/2001

Orange Beach, AL 

Richichi, Mark S ....................... 12/20/2001

Ctr Moriches, NY 

Roberts, Pamela ....................... 12/20/2001

Charlotte, NC 

Federal Register / Vol. 67, No. 1 / Wednesday, January 2, 2002 / Notices 85

Subject city, state Effective 

date 

Robinson, Cynane Ann Yetta ... 12/20/2001

Southfield, MI 

Rodebaugh, Cheryl Lynn .......... 12/20/2001

Denver, CO 

Rose, Keith D ........................... 12/20/2001

Big Rapids, MI 

Roudebush, Mark D ................. 12/20/2001

Cordova, TN 

Rouselle, Dionne Marie ............ 12/20/2001

Memphis, TN 

Rubinstein, David M ................. 12/20/2001

Tamarac, FL 

Schwirian, Jay A ....................... 12/20/2001

White Oak, PA 

Smith, Terrance Herbert ........... 12/20/2001

Sioux Falls, SD 

Smith, William H III ................... 12/20/2001

Philadelphia, PA 

Sparks, Darlene V .................... 12/20/2001

Annandale, VA 

Stevens, Joanne K ................... 12/20/2001

Broadview Hgts, OH 

Strasser, Robert T .................... 12/20/2001

Lake Zurich, IL 

Thompson, Emma R ................ 12/20/2001

Lithonia, GA 

Van Brookhoven, Gloria ........... 12/20/2001

Atlanta, GA 

Vodvarka, James M .................. 12/20/2001

Steubenville, OH 

Webb, James R ........................ 12/20/2001

Shawnee Mission, KS 

Wohlschlaeger, Michael Alan ... 12/20/2001

Panama City Bch, FL 

Wolf, Jacob M ........................... 12/20/2001

Akron, OH 

Wright, Bill G ............................ 12/20/2001

Lincoln, NE 

Yoder, Patricia L ....................... 12/20/2001

Ocklawaha, FL 

Young-Cheney, Joan E ............ 12/20/2001

Creswell, OR 

Peer Review Organization Cases

Hinkley, Bruce Stanton ............. 11/14/2001

Dallas, TX 

Dated: December 3, 2001. 

Calvin Anderson, Jr., 

Director, Health Care Administrative 

Sanctions, Office of Inspector General.

[FR Doc. 01–32156 Filed 12–31–01; 8:45 am] 

BILLING CODE 4150–04–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing

AGENCY: National Institutes of Health, 

Public Health Service, DHHS.

ACTION: Notice.

SUMMARY: The inventions listed below 

are owned by agencies of the U.S. 

Government and are available for 

licensing in the U.S. in accordance with 

35 U.S.C. 207 to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing.

ADDRESSES: Licensing information and 

copies of the U.S. patent applications 

listed below may be obtained by 

contacting Peter A. Soukas, J.D., at the 

Office of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, 

Maryland 20852–3804; telephone: 301/

496–7056 ext. 268; fax: 301/402–0220; 

e-mail: soukasp@od.nih.gov. A signed 

Confidential Disclosure Agreement will 

be required to receive copies of the 

patent applications. 

LL–37 is an Immunostimulant 

Oleg Chertov (NCI), Joost Oppenheim 

(NCI), De Yang (NCI), Qian Chen 

(NCI), Ji Wang (NCI), Mark Anderson 

(EM), Joseph Wooters (EM) 

Serial No. 09/960,876 filed 21 Sep 2001

This invention relates to use of an 

antimicrobial peptide as a vaccine 

adjuvant. LL–37 is the cleaved 

antimicrobial 37-residue C-terminal 

peptide of hCAP18, the only identified 

member in humans of a family of 

proteins called cathelicidins. LL–37/

hCAP18 is produced by neutrophils and 

various epithelial cells. LL–37 is well 

known as an antimicrobial peptide. 

However, although antimicrobial 

peptides have generally been considered 

to contribute to host innate 

antimicrobial defense, some of them 

may also contribute to adaptive 

immunity against microbial infection. 

The inventors have shown that LL–37 

utilizes formyl peptide receptor-like 1 

(FPLR1) as a receptor to activate human 

neutrophils, monocytes, and T cells. 

Since leukocytes participate in both 

innate and adaptive immunity, the fact 

that LL–37 can chemoattract human 

leukocytes may provide one additional 

mechanism by which LL–37 can 

contribute to host defense against 

microbial invasion, by participating in 

the recruitment of leukocytes to sites of 

infection. The invention claims methods 

of enhancing immune responses 

through the administration of LL–37 

alone, in conjunction with a vaccine, 

and methods of treating autoimmune 

diseases. The invention is further 

described in Chertov et. al., ‘‘LL–37, the 

neutrophil granule- and epithelial cellderived cathelicidin, utilizes formyl 

peptide receptor-like 1 (FPRL1) as a 

receptor to chemoattract human 

peripheral blood neutrophils, 

monocytes, and T cells,’’ J Exp. Med. 

2000 Oct 2;192(7):1069–74. 

A Method for Bioconjugation Using 

Diels-Alder Cycloaddition 

Vince Pozsgay (NICHD) 

Serial Number 09/919,637 filed 01 Aug 

2001

This invention relates to a new 

method for the synthesis of conjugate 

vaccines using the Diels-Alder 

cycloaddition reaction to covalently 

attach a carbohydrate antigen from a 

pathogen to a protein carrier. The DielsAlder reaction has not been extended to 

conjugation involving biopolymers or 

other types of polymeric materials. 

Advantages of this method are that 

cross-linking during conjugation is 

entirely avoided in addition to the mild 

chemical conditions under which this 

synthesis method proceeds. Diels-Alder 

reactions commonly take place in hightemperature environments; the method 

contemplated by this invention takes 

place at much lower temperatures. In 

addition to claiming methods of 

synthesis for conjugate vaccines using 

the Diels-Alder cycloaddition, the 

patent application claims vaccines 

produced utilizing the method, and 

methods of inducing antibodies which 

react with the polysaccharides 

contemplated by the invention. 

Identification of New Small RNAs and 

ORFs 

Susan Gottesman (NCI), Gisela Storz 

(NICHD), Karen Wassarman (NICHD), 

Francis Repoila (NCI), Carsten 

Rosenow (EM) 

Serial No. 60/266,402 filed 01 Feb 2001

The inventors have isolated a number 

of previously unknown sRNAs found in 

E. coli. Previous scientific publications 

by the inventors and others regarding 

sRNAs have shown these sRNAs to 

serve important regulatory roles in the 

cell, such as regulators of virulence and 

survival in host cells. Prediction of the 

presence of genes encoding sRNAs was 

accomplished by combining sequence 

information from highly conserved 

intergenic regions with information 

about the expected transcription of 

neighboring genes. Microarray analysis 

also was used to identify likely 

candidates. Northern blot analyses were 

then carried out to demonstrate the 

presence of the sRNAs. Three of the 

sRNAs claimed in the invention regulate 

(candidates 12 and 14, negatively and 

candidate 31, positively) expression of 

RpoS, a major transcription factor in 

bacteria that is important in many 

pathogens because it regulates (amongst 

other things) virulence. The inventors’

data show that these sRNAs are highly